Wells Fargo & Company Biocryst Pharmaceuticals Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 67,997 shares of BCRX stock, worth $514,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,997

Previous 72,444 6.14%

Holding current value

$514,737

Previous $447,000 15.44%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$6.41 - $8.69 $28,505 - $38,644	-4,447 Reduced 6.14%	67,997 $516,000
Q2 2024 Aug 13, 2024	BUY	$4.13 - $6.79 $40,420 - $66,453	9,787 Added 15.62%	72,444 $447,000
Q1 2024 May 10, 2024	BUY	$4.89 - $7.65 $33,340 - $52,157	6,818 Added 12.21%	62,657 $318,000
Q4 2023 Feb 09, 2024	SELL	$4.98 - $6.77 $679,027 - $923,096	-136,351 Reduced 70.95%	55,839 $334,000
Q3 2023 Nov 13, 2023	SELL	$6.71 - $7.92 $426,024 - $502,848	-63,491 Reduced 24.83%	192,190 $1.36 Million
Q2 2023 Aug 15, 2023	BUY	$6.96 - $8.81 $499,254 - $631,958	71,732 Added 39.0%	255,681 $1.8 Million
Q1 2023 May 12, 2023	BUY	$7.94 - $11.84 $1.38 Million - $2.06 Million	174,123 Added 1772.06%	183,949 $1.53 Million
Q4 2022 Feb 13, 2023	SELL	$10.5 - $14.2 $77,920 - $105,378	-7,421 Reduced 43.03%	9,826 $112,000
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $58,535 - $80,344	-5,425 Reduced 23.93%	17,247 $216,000
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $1.04 Million - $2.37 Million	-132,280 Reduced 85.37%	22,672 $240,000
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $707,957 - $1.21 Million	-61,242 Reduced 28.33%	154,952 $2.52 Million
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $172,429 - $238,439	15,423 Added 7.68%	216,194 $3 Million
Q3 2021 Nov 15, 2021	SELL	$14.21 - $17.65 $2,273 - $2,824	-160 Reduced 0.08%	200,771 $2.89 Million
Q2 2021 Aug 16, 2021	SELL	$9.5 - $17.24 $8,246 - $14,964	-868 Reduced 0.43%	200,931 $3.18 Million
Q1 2021 May 13, 2021	SELL	$7.37 - $13.61 $1.99 Million - $3.68 Million	-270,578 Reduced 57.28%	201,799 $2.05 Million
Q4 2020 Feb 09, 2021	BUY	$3.37 - $8.61 $12,438 - $31,779	3,691 Added 0.79%	472,377 $3.52 Million
Q3 2020 Nov 05, 2020	SELL	$3.43 - $5.53 $39,225 - $63,241	-11,436 Reduced 2.38%	468,686 $1.61 Million
Q2 2020 Aug 13, 2020	BUY	$1.9 - $5.61 $736,647 - $2.18 Million	387,709 Added 419.54%	480,122 $2.29 Million
Q1 2020 May 14, 2020	BUY	$1.6 - $4.11 $147,860 - $379,817	92,413 New	92,413 $184,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Biocryst Pharmaceuticals Inc Transaction History